At the intersection of aging global demographics and cutting-edge ophthalmic innovation lies the Choroidal Neovascularization (CNV) market, a sector on the cusp of dramatic transformation. CNV, the destructive growth of abnormal blood vessels beneath the retina, is the principal cause of severe vision loss in age-related macular degeneration (AMD) and a significant threat in other…